litlas
Log inCreate account

John E. Shively

Active 1970–2024

121
Papers
18,141
Citations
87
h-index
119
i10-index

Citations

Citations per year for John E. Shively1970: 1 citations1971: 3 citations1972: 1 citations1973: 2 citations1974: 2 citations1975: 5 citations1976: 5 citations1978: 6 citations1979: 10 citations1980: 17 citations1981: 28 citations1982: 44 citations1983: 51 citations1984: 91 citations1985: 79 citations1986: 102 citations1987: 109 citations1988: 111 citations1989: 142 citations1990: 166 citations1991: 145 citations1992: 103 citations1993: 108 citations1994: 98 citations1995: 136 citations1996: 145 citations1997: 164 citations1998: 146 citations1999: 161 citations2000: 139 citations2001: 110 citations2002: 123 citations2003: 110 citations2004: 113 citations2005: 154 citations2006: 110 citations2007: 127 citations2008: 132 citations2009: 127 citations2010: 101 citations2011: 86 citations2012: 97 citations2013: 84 citations2014: 63 citations2015: 62 citations2016: 61 citations2017: 49 citations2018: 54 citations2019: 180 citations2020: 216 citations2021: 241 citations2022: 174 citations2023: 156 citations2024: 253 citations2025: 88 citations2026: 5 citations1977: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,373 citing papers, 40.1% of this breakdownUnited Kingdom: 367 citing papers, 6.2% of this breakdownChina: 364 citing papers, 6.2% of this breakdownGermany: 329 citing papers, 5.6% of this breakdownJapan: 328 citing papers, 5.6% of this breakdownFrance: 213 citing papers, 3.6% of this breakdownCanada: 200 citing papers, 3.4% of this breakdownSweden: 186 citing papers, 3.1% of this breakdownSwitzerland: 158 citing papers, 2.7% of this breakdownAustralia: 149 citing papers, 2.5% of this breakdownItaly: 133 citing papers, 2.3% of this breakdownNetherlands: 127 citing papers, 2.1% of this breakdown
0%40.1%Other 16.6%

Institutions

Fields

  • Biochemistry, Genetics and Molecular Biology40.7%
  • Medicine36.3%
  • Immunology and Microbiology7.5%
  • Neuroscience5.8%
  • Pharmacology, Toxicology and Pharmaceutics4.4%
  • Chemistry1.1%
  • Other4.2%

Topics

  • Monoclonal and Polyclonal Antibodies Research4%
  • Glycosylation and Glycoproteins Research2.8%
  • Inflammasome and immune disorders2.8%
  • Radiopharmaceutical Chemistry and Applications2.8%
  • Cell death mechanisms and regulation2.7%
  • Pharmacogenetics and Drug Metabolism2.1%
  • Other82.8%

Coauthors

All papers

Open in search
  1. A novel heterodimeric cysteine protease is required for interleukin-1βprocessing in monocytes

    Authors: Nancy A. Thornberry, Herbert G. Bull, Jimmy Calaycay, Kevin T. Chapman, Andrew Howard, Matthew J. Kostura, Douglas K. Miller, Susan M. Molineaux, Jeffrey R. Weidner, John Auniņš, Keith Elliston, Julia M. Ayala, Francesca J. Casano, Jayne Chin, G J Ding, Linda A. Egger, Erin P. Gaffney, G Limjuco, Oksana Palyha, S Raju, Anna Rolando, J. Paul Salley, Ting-Ting Yamin, Terry D. Lee, John E. Shively, Malcolm MacCross, Richard A. Mumford, John A. Schmidt, Michael J. Tocci - Nature 1992 cited by 2,580

  2. Clinical implications of carcinoembryonic antigen distribution in serum exosomal fraction—Measurement by ELISA

    Authors: Shozo Yokoyama, Akihiro Takeuchi, Shunsuke Yamaguchi, Yasuyuki Mitani, Takashi Watanabe, Kenji Matsuda, Tsukasa Hotta, John E. Shively, Hiroki Yamaue - PLoS ONE 2017 cited by 108

  3. Effective Targeting of TAG72+ Peritoneal Ovarian Tumors via Regional Delivery of CAR-Engineered T Cells

    Authors: John P. Murad, Anna Kozłowska, Hee Jun Lee, Maya Ramamurthy, Wen-Chung Chang, Paul J. Yazaki, David Colcher, John E. Shively, Mihaela Cristea, Stephen J. Forman, Saul J. Priceman - Frontiers in Immunology 2018 cited by 146

  4. Tumor Uptake of 64Cu-DOTA-Trastuzumab in Patients with Metastatic Breast Cancer

    Authors: Joanne Mortimer, James R. Bading, Jinha Park, Paul Frankel, Mary Carroll, Tri Manh Tran, Erasmus Poku, Russell C. Rockne, Andrew Raubitschek, John E. Shively, David Colcher - Journal of Nuclear Medicine 2017 cited by 95

  5. Daratumumab induces mechanisms of immune activation through CD38+ NK cell targeting

    Authors: Domenico Viola, Ada Donà, Enrico Caserta, Estelle Troadec, Francesca Besi, Tinisha McDonald, Lucy Ghoda, Emine Gulsen Gunes, James F. Sanchez, Jihane Khalife, Marianna Martella, Chatchada Karanes, Myo Htut, Xiuli Wang, Michael Rosenzweig, Arnab Chowdhury, Douglas W. Sborov, Rodney R. Miles, Paul J. Yazaki, Todd Ebner, Craig C. Hofmeister, Stephen J. Forman, Steven T. Rosen, Guido Marcucci, John E. Shively, Jonathan J. Keats, Amrita Krishnan, Flavia Pichiorri - Leukemia 2020 cited by 88

  6. PET of Adoptively Transferred Chimeric Antigen Receptor T Cells with 89Zr-Oxine

    Authors: Michael R. Weist, Renate Starr, Brenda Aguilar, Junie Chea, Joshua K. Miles, Erasmus Poku, Ethan Gerdts, Xin Yang, Saul J. Priceman, Stephen J. Forman, David Colcher, Christine E. Brown, John E. Shively - Journal of Nuclear Medicine 2018 cited by 170

  7. Evidence that cathelicidin peptide LL‐37 may act as a functional ligand for CXCR2 on human neutrophils

    Authors: Zhifang Zhang, Gregory Cherryholmes, Frances Chang, David M. Rose, Ingrid U. Schraufstätter, John E. Shively - European Journal of Immunology 2009 cited by 116

  8. Use of 64Cu-DOTA-Trastuzumab PET to Predict Response and Outcome of Patients Receiving Trastuzumab Emtansine for Metastatic Breast Cancer: A Pilot Study

    Authors: Joanne Mortimer, James R. Bading, Paul Frankel, Mary Carroll, Yuan Yuan, Jinha Park, Lusine Tumyan, Nikita Gidwaney, Erasmus Poku, John E. Shively, David Colcher - Journal of Nuclear Medicine 2021 cited by 35

  9. The HopQ-CEACAM Interaction Controls CagA Translocation, Phosphorylation, and Phagocytosis of Helicobacter pylori in Neutrophils

    Authors: Ina‐Kristin Behrens, Benjamin Busch, Hellen Ishikawa‐Ankerhold, Pia Palamides, John E. Shively, Cliff Stanners, Carlos H.F. Chan, Nelly Leung, Scott D. Gray‐Owen, Rainer Haas - mBio 2020 cited by 49

  10. Designing combination therapies for cancer treatment: application of a mathematical framework combining CAR T-cell immunotherapy and targeted radionuclide therapy

    Authors: Vikram Adhikarla, Dennis Awuah, Enrico Caserta, Megan Minnix, Maxim Kuznetsov, Amrita Krishnan, Jefferey Y. C. Wong, John E. Shively, Xiuli Wang, Flavia Pichiorri, Russell C. Rockne - Frontiers in Immunology 2024 cited by 19

  11. Cytochrome P450c17 (steroid 17 alpha-hydroxylase/17,20 lyase): cloning of human adrenal and testis cDNAs indicates the same gene is expressed in both tissues.

    Authors: Bon‐chu Chung, J Picado-Leonard, Mitsuru Haniu, Michał Bieńkowski, Peter F. Hall, John E. Shively, W L Miller - National Academy of Sciences, Proceedings of the National Academy of Sciences 1987 cited by 451

  12. Aptamer-Drug Conjugates of Active Metabolites of Nucleoside Analogs and Cytotoxic Agents Inhibit Pancreatic Tumor Cell Growth

    Authors: Sorah Yoon, Kai‐Wen Huang, Vikash Reebye, Duncan Spalding, Teresa M. Przytycka, Yijie Wang, Piotr Swiderski, Lin Li, Brian Armstrong, Isabella Reccia, Dimitris Zacharoulis, Konstantinos Dimas, Tomokazu Kusano, John E. Shively, Nagy Habib, John J. Rossi - Molecular Therapy — Nucleic Acids 2016 cited by 79

  13. Tumor regression and immunity in combination therapy with anti-CEA chimeric antigen receptor T cells and anti-CEA-IL2 immunocytokine

    Authors: Seung E. Cha, Maciej Kujawski, Paul J. Yazaki, Christine E. Brown, John E. Shively - OncoImmunology 2021 cited by 46

  14. Identifying CD38+ cells in patients with multiple myeloma: first-in-human imaging using copper-64–labeled daratumumab

    Authors: Amrita Krishnan, Vikram Adhikarla, Erasmus Poku, Joycelynne Palmer, Ammar Chaudhry, Van Eric Biglang-awa, Nicole Bowles, Nitya Nathwani, Michael Rosenzweig, Firoozeh Sahebi, Chatchada Karanes, Jennifer Simpson, James F. Sanchez, Dave Yamauchi, Maria Parayno, Arnab Chowdhury, Enrico Caserta, Guido Marcucci, Russell C. Rockne, Anna M. Wu, Jeffrey Y.C. Wong, Stephen J. Forman, David Colcher, Paul J. Yazaki, John E. Shively, Flavia Pichiorri - Blood Advances 2020 cited by 46

  15. Comparison of CD38-Targeted α- Versus β-Radionuclide Therapy of Disseminated Multiple Myeloma in an Animal Model

    Authors: Megan Minnix, Vikram Adhikarla, Enrico Caserta, Erasmus Poku, Russell C. Rockne, John E. Shively, Flavia Pichiorri - Journal of Nuclear Medicine 2020 cited by 40

  16. Functional Imaging of Human Epidermal Growth Factor Receptor 2–Positive Metastatic Breast Cancer Using 64Cu-DOTA-Trastuzumab PET

    Authors: Joanne Mortimer, James R. Bading, David Colcher, Peter S. Conti, Paul Frankel, Mary Carroll, Shan Tong, Erasmus Poku, Joshua K. Miles, John E. Shively, Andrew Raubitschek - Journal of Nuclear Medicine 2013 cited by 159

  17. CEACAM1 Negatively Regulates IL-1β Production in LPS Activated Neutrophils by Recruiting SHP-1 to a SYK-TLR4-CEACAM1 Complex

    Authors: Rongze Lu, Hao Pan, John E. Shively - PLoS Pathogens 2012 cited by 79

  18. Biodistribution of Intra-Arterial and Intravenous Delivery of Human Umbilical Cord Mesenchymal Stem Cell-Derived Extracellular Vesicles in a Rat Model to Guide Delivery Strategies for Diabetes Therapies

    Authors: Junfeng Li, Hirotake Komatsu, Erasmus Poku, Tove Olafsen, Kelly X. Huang, Lina A. Huang, Junie Chea, Nicole Bowles, Betty Chang, Jeffrey Rawson, Jiangling Peng, Anna M. Wu, John E. Shively, Fouad Kandeel - Pharmaceuticals 2022 cited by 17

  19. Cell Type and Culture Condition–Dependent Alternative Splicing in Human Breast Cancer Cells Revealed by Splicing-Sensitive Microarrays

    Authors: Chunxia Li, Mitsuo Kato, Lily Shiue, John E. Shively, Manuel Ares, Ren-Jang Lin - Cancer Research 2006 cited by 97

  20. Phase I Study of Yttrium-90 Radiolabeled M5A Anti-Carcinoembryonic Antigen Humanized Antibody in Patients with Advanced Carcinoembryonic Antigen Producing Malignancies

    Authors: David Akhavan, Paul J. Yazaki, Dave Yamauchi, Jennifer Simpson, Paul Frankel, James R. Bading, David Colcher, Kofi Poku, Yi‐Jen Chen, Dean Lim, Mihaela Cristea, Anna M. Wu, John E. Shively, Jeffrey Y.C. Wong - Cancer Biotherapy and Radiopharmaceuticals 2020 cited by 28

  21. A Mathematical Modeling Approach for Targeted Radionuclide and Chimeric Antigen Receptor T Cell Combination Therapy

    Authors: Vikram Adhikarla, Dennis Awuah, Alexander B. Brummer, Enrico Caserta, Amrita Krishnan, Flavia Pichiorri, Megan Minnix, John E. Shively, Jeffrey Y.C. Wong, Xiuli Wang, Russell C. Rockne - Cancers 2021 cited by 17

  22. Urotensin II: a somatostatin-like peptide in the caudal neurosecretory system of fishes.

    Authors: David Pearson, John E. Shively, Brian R. Clark, Irving I. Geschwind, Marylynn Barkley, R.S. Nishioka, Howard A. Bern - National Academy of Sciences, Proceedings of the National Academy of Sciences 1980 cited by 393

  23. Minibody: A novel engineered anti-carcinoembryonic antigen antibody fragment (single-chain Fv-CH3) which exhibits rapid, high-level targeting of xenografts.

    Authors: Songhua Hu, L Shively, Andrew Raubitschek, Mark A. Sherman, Lawrence E. Williams, J Y Wong, John E. Shively, Anna M. Wu - 1996 cited by 337

  24. Loss of CEACAM1 is associated with poor prognosis and peritoneal dissemination of patients with gastric cancer

    Authors: Akihiro Takeuchi, Shozo Yokoyama, Mikihito Nakamori, Masaki Nakamura, Toshiyasu Ojima, Shunsuke Yamaguchi, Yasuyuki Mitani, John E. Shively, Hiroki Yamaue - Scientific Reports 2019 cited by 30